NCT05515770View on ClinicalTrials.gov

The Implementation of Pre-exposure Prophylaxis of Injectable Cabotegravir

PHASE3RecruitingINTERVENTIONAL
Enrollment

1,200

Participants

Timeline

Start Date

September 20, 2022

Primary Completion Date

October 31, 2025

Study Completion Date

February 28, 2026

Conditions
HIV Infections
Interventions
DRUG

Cabotegravir Injection

Long action cabotegravir injection

Trial Locations (1)

21040-360

RECRUITING

Instituto Nacional de Infectologia Evandro Chagas/ FIOCRUZ, Rio de Janeiro

All Listed Sponsors
collaborator

Beatriz Grinsztejn

UNKNOWN

collaborator

Thiago Torres

UNKNOWN

collaborator

Valdilea Gonçalves

UNKNOWN

collaborator

Brenda Hoagland

UNKNOWN

lead

Evandro Chagas National Institute of Infectious Disease

OTHER